Drugs / EO2040
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05350501 | Mar 2023 → Jan 2024 | colorectal cancer | Enterome | Terminated | No outcome recorded Stop: Enrollment |
Press releases naming this drug 1 release
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EO2040 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05350501 ↗ |
| Modality | Vaccine | “therapeutic peptide vaccine” NCT05350501 ↗ |